glp 1 agonists and pancreatitis The pancreatic extrapancreatic effect of GLP-1. GLP-1, glucagon Pancreatitis risk from GLP1 use
Description
Compared to control, significant reductions in intracranial pressure were seen acutely at 2.5 h and 24 h, but also at 12 weeks [101]
So there's Liraglutide, which is a daily injection
(2010a)
Sun Z, Li P, Wang X, et al
Lancet Diabetes Endocrinol 2014;2:289297
For example, a randomised trial in patients with type 2 diabetes found that liraglutide (1.2 or 1.8 mg) significantly improved emotional well-being and general perceived health compared to glimepiride (8 mg daily) [4]
